Jirge PR, Chougule SM, Gavali VG, Bhomkar DA. Impact of dehydroepiandrosterone on clinical outcome in poor responders: A pilot study in women undergoing in vitro fertilization, using bologna criteria.
J Hum Reprod Sci 2014;
7:175-80. [PMID:
25395742 PMCID:
PMC4229792 DOI:
10.4103/0974-1208.142477]
[Citation(s) in RCA: 21] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2014] [Revised: 05/26/2014] [Accepted: 09/10/2014] [Indexed: 12/02/2022] Open
Abstract
OBJECTIVE:
To evaluate the role of dehydroepiandrosterone (DHEA) supplementation in women with poor ovarian response (POR) undergoing in vitro fertilization (IVF).
DESIGN:
Prospective case-control study.
SETTING:
Private tertiary fertility clinic.
MATERIALS AND METHODS:
31 infertile women with POR diagnosed as per the Bologna criteria.
INTERVENTIONS:
DHEA supplementation for 2 months and a subsequent IVF cycle, after two previous IVF cycles with POR.
MAIN OUTCOME MEASURE(S):
Dose and duration of gonadotropin therapy, oocyte yield, embryo number and quality, pregnancy and live birth rate.
RESULTS:
No difference was seen in gonadotropin requirement before and after DHEA supplementation. There was a significant increase in total and metaphase II oocytes (5.9 ± 0.68 vs. 2.73 ± 0.24; 4.45 ± 0.47 vs. 2.09 ± 0.26), fertilization (3.65 ± 0.49 vs. 2.00 ± 0.27), Grade I embryos (1.52 ± 0.25 vs. 0.55 ± 0.18), pregnancy rate (30% vs. 9.1%) and live birth rate (25% vs 0%) in those who completed the cycle, following DHEA supplementation.
CONCLUSIONS:
Dehydroepiandrosterone supplementation results in an improvement in oocyte yield, embryo quality, and live birth rate in a group of women with POR having undergone at least two previous failures due to POR.
Collapse